Sign Up to like & get
recommendations!
1
Published in 2022 at "Biomaterials science"
DOI: 10.1039/d1bm01944a
Abstract: Employing hypoxia-activated prodrugs is an appealing oncotherapy strategy, but limited by insufficient tumor hypoxia. Moreover, a standalone prodrug fails to treat tumors satisfactorily due to tumor complexity. Herein, a nanosystem (TPZ@FeMSN-GOX) was established for triple…
read more here.
Keywords:
hypoxia;
therapy;
tpz femsn;
hypoxia activated ... See more keywords